Technology, Science, & Me!: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology, Science, & Me!.

Press releases published on October 5, 2026

Uniti Group Inc. To Report Third Quarter 2026 Financial Results and Host Conference Call
ONEOK Schedules Third-Quarter 2026 Conference Call and Webcast
authID Announces Pricing of Up To $1,350,000 Private Placement Offering
企業轉型不只缺技術,更缺整合:優思顧問觀點看傳統企業的升級路徑
Merlin, Inc. To Participate in Upcoming Investor Conferences
Government Business Results Expands Public Sector Go-to-Market Services with New Partner Marketing Practice
Sprout Social to Announce Third Quarter 2026 Financial Results on November 3, 2026
Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026
Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121
NanoXplore Announces the Creation of an Advisory Board for Its Subsidiary VoltaXplore and Appoints Galvion Founder and Executive Chairman Jonathan Blanshay as Inaugural Member
NanoXplore annonce la création d’un Conseil consultatif pour sa filiale VoltaXplore et nomme Jonathan Blanshay, fondateur et président exécutif de Galvion, à titre de membre inaugural
CTW to Announce Fiscal Year 2026 Financial Results on October 15 and Host Earnings Webinar on October 16
Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
Polar Power Rejects Solidion All-Cash Offer for Company Assets
Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting
Leonardo DRS Completes Training and Delivery of INOD Block III Thermal Weapon Sights for the Australian Army
iCell Gene Therapeutics Announces Upcoming Conference Presentations
ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology, Science, & Me!

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.